These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. FDG uptake in liposclerosing myxofibrous tumor causes upstaging of Hodgkin lymphoma. Kim J; Chen W; Resnik C; Dilsizian V; Chen Q; Kimball AS Clin Nucl Med; 2015 Apr; 40(4):325-7. PubMed ID: 25290293 [TBL] [Abstract][Full Text] [Related]
4. A rare case of primary thymic Hodgkin lymphoma in an elderly patient detected by 18F-FDG PET/CT. Treglia G; Lococo F; Petrone G; Stefanelli A; Carnassale G; Calcagni ML; Granone P; Giordano A Clin Nucl Med; 2013 May; 38(5):e236-8. PubMed ID: 23377412 [TBL] [Abstract][Full Text] [Related]
5. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed? Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match? Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM Ann Nucl Med; 2015 Feb; 29(2):132-7. PubMed ID: 25348549 [TBL] [Abstract][Full Text] [Related]
7. Acute varicella infection mimics recurrent Hodgkin's disease on F-18 FDG PET/CT. Sheehy N; Israel DA Clin Nucl Med; 2007 Oct; 32(10):820-1. PubMed ID: 17885370 [TBL] [Abstract][Full Text] [Related]
8. [¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies. Terezakis SA; Hunt MA; Kowalski A; McCann P; Schmidtlein CR; Reiner A; Gönen M; Kirov AS; Gonzales AM; Schöder H; Yahalom J Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):615-22. PubMed ID: 20933343 [TBL] [Abstract][Full Text] [Related]
9. FDG PET/CT flip flop phenomenon in treated lymphoma of bone. Lin EC Clin Nucl Med; 2006 Dec; 31(12):803-5. PubMed ID: 17117078 [TBL] [Abstract][Full Text] [Related]
10. 18F-FDG-PET/CT in the surveillance of patients with lymphoma: detection of asymptomatic recurrences. García Vicente AM; Bellón Guardia M; Soriano Castrejón A; Calle Primo C; Cordero García JM; Palomar Muñoz A; Pilkington Woll JP; Talavera Rubio MP; Hernández Ruiz B Rev Esp Med Nucl Imagen Mol; 2012; 31(1):22-7. PubMed ID: 21742419 [TBL] [Abstract][Full Text] [Related]
11. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma. Qiu L; Chen Y; Wu J Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577 [TBL] [Abstract][Full Text] [Related]
12. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas. Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687 [TBL] [Abstract][Full Text] [Related]
13. [Diagnostic difficulties caused by a pulmonary infiltrate]. Simon Z; Jóna A; Miltényi Z; Páyer E; Lieber A; Szilasi M; Illés A Orv Hetil; 2012 Jul; 153(27):1077-81. PubMed ID: 22759748 [TBL] [Abstract][Full Text] [Related]
14. Disseminated osteomyelitis or bone metastases of breast cancer: (18)F-FDG-PET/CT helps unravel an unusual presentation. Mandegaran R; Debard A; Alvarez M; Marchou B; Massip P; Wagner T Ann Nucl Med; 2014 Feb; 28(2):167-71. PubMed ID: 24203488 [TBL] [Abstract][Full Text] [Related]
15. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility. Basu S; Li G; Bural G; Alavi A Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692 [TBL] [Abstract][Full Text] [Related]
16. Multiple intraabdominal purulent collections demonstrated on FDG PET/CT in staging of non-Hodgkin lymphoma. Tow J; Loh H; Bui C; Fuller S; Mansberg R Clin Nucl Med; 2012 Feb; 37(2):210-3. PubMed ID: 22228357 [TBL] [Abstract][Full Text] [Related]
17. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management. Pelosi E; Penna D; Deandreis D; Chiappella A; Skanjeti A; Vitolo U; Bisi G Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):9-16. PubMed ID: 18235420 [TBL] [Abstract][Full Text] [Related]
18. [Resistance to first line chemotherapy treatment in a patient diagnosed of nodular lymphocyte-predominant Hodgkin's lymphoma identified by 18F-FDG PET/CT: diagnostic and therapeutic implications]. Banzo J; Ubieto MA; Giraldo P; Razola P; Prats E; Tardin L; Santapau A; Parra A; Rambalde EF; Velilla J Rev Esp Med Nucl Imagen Mol; 2012; 31(2):89-92. PubMed ID: 21620527 [TBL] [Abstract][Full Text] [Related]
19. FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. Paes FM; Kalkanis DG; Sideras PA; Serafini AN Radiographics; 2010 Jan; 30(1):269-91. PubMed ID: 20083598 [TBL] [Abstract][Full Text] [Related]
20. Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed? Ulaner GA; Magnan H; Healey JH; Weber WA; Meyers PA AJR Am J Roentgenol; 2014 Apr; 202(4):859-67. PubMed ID: 24660717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]